(Tromsø 14. September 2017) Svein Lien, CEO of Biotec Pharmacon has today
purchased 50.000 shares in Biotec Pharmacon. 25.000 shares have been bought at
NOK 7,00 per share via his fully owned company Spiralen Industrier AS and 25.000
shares have been bought at NOK 6.99 per share on Svein Lien . After this
transaction holds Svein Lien and associates 600.829 shares and 160.000 options
in Biotec Pharmacon.
This information is subject to the disclosure requirements pursuant to section 5
-12 of the Norwegian Securities Trading Act.
For further information, please contact
Børge Sørvoll
CFO
+47 952 90 187
borge.sorvoll@biotec.no

